COMP <GO>
CUVL vs UNP // ALTMAN Z-SCORE & DEBT/EQUITY
Clinuvel Pharmaceuticals Limited (NASDAQ) VS. Union Pacific Corporation (NYSE) • 15-METRIC TALLY: CUVL 6
— UNP 3
■ METRIC PARITY
LAST: $5.15 (+1.58%) • MKT CAP: $257.8M
balance-sheet
—
LAST: $301.93 (+1.39%) • MKT CAP: $179.42B
balance-sheet
4.31
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CUVL VS. UNP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CUVL | UNP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 81.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 20.10% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.7x | 15.3x | -5.60 | CUVL | /valuation <GO> |
| Free Cash Flow Yield | 10.51% | 3.06% | +7.45 | CUVL | /fcf-yield <GO> |
| Operating Margin | 43.40% | 40.20% | +3.20 | CUVL | /operating-margins <GO> |
| Net Profit Margin | 37.80% | 29.10% | +8.70 | CUVL | /net-margins <GO> |
| Revenue Growth (YoY) | 5.50% | 1.10% | +4.40 | CUVL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.66% | 1.80% | -1.14 | UNP | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | 4.31 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.7 | 66.2 | -28.53 | UNP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.03 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.3x | 23.3x | -13.00 | CUVL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $257.8M | $179.42B | -$179.16B | UNP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CUVL REV | UNP REV | CUVL GROSS % | UNP GROSS % | CUVL FCF | UNP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $61.1M | $24.51B | 81.2% | — | $27.1M | $5.50B |
| FY 2024 | $57.9M | $24.25B | 81.5% | — | $20.1M | $5.89B |
| FY 2023 | — | $24.12B | — | — | — | $7.29B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CUVL // BETA —
UNP // BETA 1.03